Synbiosis has announced that a top pharmaceutical company has chosen to install its 10th Protocol automated colony counting and zone sizing system.
The Protocol systems, sited at the company's vaccine unit in Germany, are being used to speed up testing of new and existing pneumococcal and flu vaccines.
The latest Protocol system at this pharmaceutical company is being integrated into a GMP facility alongside eight other Protocol systems and will be used to accelerate manufacturing of pneumococcal vaccines by automatically counting surviving S.pneumoniae colonies post OPKA assay.
The Protocol is well designed for this because its high-resolution CCD camera can detect the tiny colonies produced very precisely.
The other Protocol system installed at this company is being used in the research laboratories to automate measuring the size of inhibition zones on SRD plates, which determines the efficacy of novel flu vaccines.
The system is suited to this application because its software analyses measurements from multiple points around the zone diameter to generate the most accurate zone sizing results.
